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Gene transfer of truncated IB prevents tubulointerstitial injury
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Gene transfer of truncated IB prevents tubulointerstitial in- [4]. Excessive protein loading of the proximal tubules
jury. results in the induction of genes encoding chemokines
Background. Severe proteinuria not only indicates the pres- and cytokines, the expressions of which are regulated byence of progressive glomerular disease, but also causes tubular
the transcription factor, nuclear factor-B (NF-B) [2].epithelial cells to produce inflammatory mediators leading to
For example, rats with proteinuria induced by proteintubulointerstitial (TI) injury. We investigated the role of nu-
clear factor-B (NF-B) in tubular epithelial cells in the devel- overload have been shown to exhibit an increase in renal
opment of proteinuria-induced TI injury. monocyte chemoattractant protein 1 (MCP-1) expres-
Methods. To specifically inhibit NF-B activation, a recom- sion in proximal tubules [5]. In vitro studies have shownbinant adenovirus vector expressing a truncated form of IB
that protein overload induces MCP-1 [6] and RANTES(AdexIBN) was injected into renal arteries of protein-over-
[7] in cultured proximal tubular cells in an NF-B depen-loaded rats, a model of TI injury characterized by infiltration
of mononuclear cells and fibrosis. dent manner. Indeed, activation of NF-B in the kidney
Results. Activation of NF-B in the renal cortex, observed has been demonstrated in models of tubulointerstitial
in protein-overloaded rats treated with a control vector, recom- injury with proteinuria [8–10] and in patients with pro-binant lacZ adenovirus, was prevented in AdexIBN-injected
teinuria [11]. Based on these findings, we consider therats. Microscopic examination revealed AdexIBN treatment
NF-B pathway to be a potentially attractive target ofto markedly attenuate proteinuria-induced TI injury. Increased
immunostaining of vascular cell adhesion molecule-1, trans- therapeutic intervention for proteinuria-induced tubulo-
forming growth factor-, and fibronectin in TI lesions also was interstitial injury.
suppressed by AdexIBN injection. Although several agents including glucocorticoids, non-Conclusions. These findings provide evidence of the critical
steroidal anti-inflammatory drugs (NSAIDs), and antiox-role of NF-B activation in TI injury and suggest the therapeu-
idants are known to inhibit NF-B activation [12], thetic potential of adenovirus-mediated IBN gene transfer into
the kidney as a means of interrupting the process of TI damage. precise role of NF-B activation needs to be addressed
using a specific inhibitor of this pathway. In addition,
since disruption of the subunits of NF-B impairs the
Chronic renal disease with massive proteinuria is ac- host immune response [13, 14], site-specific suppression
companied by tubulointerstitial injury and progressive of the NF-B pathway may be required for therapeutic
deterioration of renal function [1, 2]. It is also known applications.
that, in patients with chronic glomerulonephritis, the de- To specifically inhibit NF-B activation, we used a re-
cline in renal function correlates better with interstitial combinant adenovirus vector expressing the truncated
than with glomerular lesions [3]. The pathophysiological form of IB (AdexIBN), which lacks its N-terminal
mechanisms underlying the tubulointerstitial injury in 54 amino acids including the phosphorylation sites essen-
persistent proteinuria, however, remain unclear. tial for the activation of NF-B [15]. With this adenovirus
In recent years, several studies have indicated that vector, we previously showed TNF-–induced NF-B acti-
filtered protein is reabsorbed and accumulated in proxi- vation to be strongly suppressed in rat mesangial cells [16]
mal tubular cells, where it has an intrinsic renal toxicity and human vascular smooth muscle cells [17] in vitro.
As a model of proteinuria, we used uninephrectomized
rats with protein overload exhibiting tubulointerstitial in-Key words: tubulointerstitial injury, nuclear factor-B, adenovirus,
proteinuria, progressive renal disease, inflammation. jury characterized by accumulation of matrix proteins and
infiltration of mononuclear inflammatory cells consistingReceived for publication January 18, 2002
mainly of monocytes and T-lymphocytes [5, 18]. Expressionand in revised form August 7, 2002
Accepted for publication September 10, 2002 of vascular cell adhesion molecule-1 (VCAM-1), an NF-B
dependent molecule associated with localization and ac- 2003 by the International Society of Nephrology
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tivation of leukocytes in various inflammatory processes In experiments investigating the effects of Adex-
IBN administration on tubulointerstitial injury, uni-[19], was investigated in rats with protein overload. Ade-
novirus was injected via the renal artery since this route nephrectomized rats received daily intraperitoneal 2 g
injections of bovine serum albumin (BSA; Sigma Chemi-of adenoviral delivery has been shown to result in gene
transfer exclusively into proximal tubular cells [20]. In cal Company, St. Louis, MO, USA) starting one week
after adenoviral infection. Control rats not injected withthis study, we determined the role of renal cortical
NF-B activation in proteinuria-induced injury. adenovirus were divided into two groups, a group in-
jected with 2 g BSA and a group injected with an equiva-
lent volume of saline. Rats were sacrificed at one, two, or
METHODS
three weeks after starting the BSA injections. After per-
Recombinant adenovirus vector fusion and decapsulation, the remaining kidney was bi-
valved. One section was cut into small pieces of cortex,A recombinant adenovirus vector was constructed that
expressed the non-degraded form of the NF-B inhibitor snap frozen in liquid nitrogen, and stored at80C for de-
termination of NF-B activity. The other section was pro-IB (Adex1CAKT IBN; abbreviated AdexIBN)
as previously described [21]. This non-degraded IB cessed for histological and immunohistochemical analyses.
For determination of 24-hour urinary protein excre-(IBN) lacked the 54 amino acids of the NH2-terminus
of wild-type human IB (MAD3). A modification of the tion and 24-hour creatinine clearance, fasting animals
were placed in individual metabolic cages to collect urine.cosmid-terminal protein complex method established by
Dr. I. Saito (Tokyo University, Tokyo, Japan) [22] was Blood was collected at the time of sacrifice for determina-
tions of serum albumin, creatinine, and total cholesterol.used to construct this adenovirus vector. Purified virus
stocks were prepared by cesium chloride (CsCl) step gra- Blood pressure was measured by tail-cuff plethysmo-
graphy.dient centrifugation, as previously described [23]. A con-
trol vector, recombinant lacZ adenovirus (AdexlacZ) All procedures used in the animal experiments com-
plied with the standards described in the Guidelines forcontaining the CAG promotor, lacZ gene, which encodes
Escherichia coli -galactosidase, and polyA signal se- the Care and Use of Laboratory Animals in Keio Univer-
sity School of Medicine.quences, was kindly supplied by Dr. I. Saito [24].
Animals and experimental design X-gal staining
Coronal slices of each kidney were placed in O.C.T.Female Wistar rats (six weeks old) were purchased from
Charles River Japan (Tokyo, Japan) and housed individ- embedding compound (Tissue-Tek; Sakura Finetek, Tor-
rance, CA, USA), snap-frozen in liquid nitrogen, andually in cages. They were fed CA-1 rat chow (27% pro-
tein; Clea Japan, Inc., Tokyo, Japan) and given free access stored at80C. Frozen sections, 8m in thickness, were
cut with a cryostat and placed on poly-l-lysine-coatedto water. One week after a right uninephrectomy, the rats
were laparotomized under general anesthesia, achieved slides. The slices were fixed in Buffer A (0.2% glutaralde-
hyde, 0.1 mol/L potassium phosphate buffer, pH 7.4, 5with intraperitoneal injections of pentobarbital (10 mg/kg).
After clipping the aorta both proximally and distally mmol/L EGTA, 2 mmol/L MgCl2) at room temperature
for five minutes. After three rinses with Buffer B (0.1to the renal artery, AdexlacZ (1.0  108 PFU/mL) or
AdexIB (5.0  107 PFU/mL) dissolved in 1 mL saline mol/L potassium phosphate buffer, pH 7.4, 0.02% Noni-
det P40, 0.01% sodium-deoxycholate, 5 mmol/L EGTA,was injected into the renal artery and the clip was re-
leased three minutes after the injection. Control rats 2 mmol/L MgCl2), the tissues were stained with X-gal
solution [10 mmol/L K3Fe(CN)6, 10 mmol/L K4Fe(CN)6,received injection of 1 mL saline without the virus.
In experiments determining the duration and localiza- 0.5 mg/mL 5-bromo-4-chloro-3-indolyl -D-galactopyra-
noside; Sigma Chemical Company] in Buffer B (pH 7.4)tion of -galactosidase expression, animals were killed by
complete exsanguination under general anesthesia at day at 37C for 10 hours.
7, 14, 21, or 28 after the injection of AdexlacZ. At the
RT-PCR analysistime of sacrifice, the remaining kidney was perfused with
saline, decapsulated, and processed for X-gal staining. Total RNA was extracted from renal cortices with an
RNA extraction kit, ISOGEN (Nippon Gene Co., Tokyo,To detect gene transfer of AdexIBN into the renal
cortex, rats were sacrificed at day 1, 4, or 7 after Adex- Japan), according to the manufacturer’s instructions.
RNA isolated from each group was treated with RNase-IBN infection. The renal cortex was excised from the
perfused kidney, homogenized, quickly frozen in liquid free DNase, and cDNA was synthesized with a commer-
cial kit (Ready To Go T-Primed First-Standard Kit;nitrogen, and stored at 80C for reverse transcription-
polymerase chain reaction (RT-PCR) analysis. Rats in- Amersham Pharmacia Biotech Inc., Tokyo, Japan). The
cDNA product was amplified by PCR with the use ofjected with saline instead of virus were used as the con-
trol in this set of experiments. primers for AdexIBN (sense primer, 5	-CTCCAGCA
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GACTCCACTCCACT-3	, and antisense primer, 5	-ACA the sections were blocked sequentially with 0.3% H2O2
in methanol and 2% normal goat serum. The sectionsCCAGCCACCACCTTCTGAT-3	), yielding a 712 bp
fragment. The PCR was initiated by a five minute incuba- were incubated at room temperature for two hours with
rabbit anti-VCAM-1 (dilution 1:400; Santa Cruz Biotech-tion at 95C, followed by 35 cycles of one minute at
95C, one minute 30 seconds at 60C, and one minute nology, Inc., Santa Cruz, CA, USA), rabbit anti-rat TGF-
(dilution 1:500; R&D Systems, Minneapolis, MN, USA),30 seconds at 72C. The resulting reaction products were
analyzed by gel electrophoresis (1% agarose) using a or rabbit anti-rat fibronectin (dilution 1:500; Chemicon
International, Temecula, CA, USA) polyclonal antibod-100 bp ladder as a size marker.
ies as the primary antibodies. After three rinses with PBS,
Histological analysis goat anti-rabbit biotinylated secondary antibody at 1:1000
dilutions was applied to the sections for 60 minutes. TheCoronal sections of renal tissue were immersion-fixed
in 10% neutral-buffered formalin and embedded in par- sections were then reacted with streptavidin-biotinylated
peroxidase complex for 30 minutes, and stained withaffin. Sections were stained with periodic acid Schiff
(PAS) to determine cellular infiltration and Masson’s tetramethylbenzidine for horseradish peroxidase histo-
chemistry. After washing and cover slipping on glycerol,trichrome for fibrotic changes, and then viewed with a
microscope. The severity of tubulointerstitial scarring the sections were examined under a microscope within
24 hours. For evaluation of the immunostaining of TGF-and glomerulosclerosis was graded semiquantitatively
(1 through 4) in a blinded manner, and the mean score and fibronectin, each tubulointerstitial grid field was
graded semiquantitatively (0 through 4) in a blindedwas calculated according to a previously described scor-
ing method [25, 26]. Tubulointerstitial scarring was manner and the mean score was calculated according to
a previously described scoring method [29–31].scored as follows: 1 
 normal tubules and interstitium;
2 
 mild tubular atrophy and interstitial fibrosis; 3 

Extraction of nuclear proteins from renalmoderate tubular atrophy and dilation with marked in-
cortex homogenatesterstitial fibrosis; 4 
 end-stage kidney with extensive
interstitial fibrosis and few remaining atrophic tubules. Nuclear protein extracts from cortical tissue were pre-
pared according to a previously described method [32],A score was given to each microscopic field viewed at a
magnification of 200. The glomerulosclerosis scoring with minor modifications [8]. Two hundred mg of cortical
tissue were homogenized with a glass Teflon homoge-system was as follows: 1 
 normal glomeruli; 2 
 pres-
ence of mild segmental glomerulosclerosis affecting nizer in 400 L of ice-cold buffer A [10 mmol/L HEPES,
pH 7.9, 10 mmol/L mol/L KCl, 2 mmol/L MgCl2, and25% of the glomerular tuft; 3 
 moderate segmental
sclerosis affecting 25 to 50% of the glomerular tuft; 4 
 0.1 mmol/L ethylenediaminetetraacetic acid (EDTA)],
a protease inhibitor cocktail tablet (Roche Moleculardiffuse severe glomerulosclerosis affecting 50% of the
tuft, including glomeruli with total tuft obliteration, fi- Biochemicals, Mannheim, Germany)] followed by addi-
tion of 65 L of 2% Nonidet-P40. The mixture was vor-brosis, and obsolescence. The scores for tubulointersti-
tial scarring and glomerulosclerosis in each rat were ob- texed, and then centrifuged at 13,000 g for five minutes.
The supernatant was removed, and the pellet was resus-tained by the examination of 25 to 50 cortical fields and
glomeruli, respectively, per kidney. The mean number of pended in 60 L of Buffer B [50 mmol/L HEPES, 10%
(vol/vol) glycerol, 300 mmol/L NaCl, 50 mmol/L KCl,interstitial mononuclear cells was calculated in a blinded
manner by averaging the total number of mononuclear a protease inhibitor cocktail tablet]. The mixture was
centrifuged at 13,000  g for 10 minutes. The susperna-cells in the interstitium in 30 randomly selected high-
power (200) cortical fields as previously described [27]. tant included nuclear protein, and was diluted to a stan-
dard concentration of 3 g/L. The protein concentra-
Immunohistochemistry of VCAM-1, transforming tions were determined by the Bradford method (Bio-Rad
growth factor-, and fibronectin Laboratories. Hercules, CA, USA) [33].
Expression of VCAM-1, transforming growth factor-
Electrophoretic mobility shift assay and densitometry(TGF-), and fibronectin was detected by immunostain-
ing according to a previously described method [28], with Double stranded NF-B consensus oligonucleotides
(5	-AGTTGAGGGGACTTTCCCAGGC-3	; Promega,minor modifications. Coronal sections of renal tissue
were immersion-fixed in 4% buffered-paraformaldehyde Madison, WI, USA) were end labeled with [32P]--ATP
(Amersham Life Science Inc. Sydney, Australia). Un-for 12 hours and washed with 10%, 15%, and 20% su-
crose in phosphate-buffered saline (PBS) for four hours incorporated label was removed with a QIAquick spin
column (Qiagen K.K., Valencia, CA, USA). The bindingeach time and then embedded in O.C.T. These sections
were snap-frozen in liquid nitrogen, and stored at80C. reaction was performed for 30 minutes at room tempera-
ture and the binding mixture contained 5 g of nuclearFrozen sections, 8 m in thickness, were cut with a cryo-
stat and air dried. After being washed in PBS (pH 7.4), protein extract, 2 L of gel shift binding 5 buffer [20%
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Fig. 1. In vivo gene transfer of -galactosidase into proximal tubular cells. AdexlacZ was injected into the renal artery and the expression of
-galactosidase was detected as a blue area in tubular epithelial cells 7 (A ), 14 (B ), and 21 (C ) days after adenoviral injection (original magnification
100). There was no X-gal staining in the liver of a rat 7 days after injection of AdexlacZ into the renal artery (D, original magnification 100)
or in the renal cortex of a rat 7 days after injection of saline into the renal artery (E, original magnification 100).
Fig. 2. Reverse transcription-polymerase chain
reaction (RT-PCR) of renal cortical mRNA
for IBN transcripts. RT-PCR was per-
formed with total RNA extracted from the
renal cortices of rats 1, 4, and 7 days after
injection of AdexIBN or saline (control) in
the presence and absence of reverse tran-
scriptase (RT). As a positive control, the prod-
uct from AdexIBN itself was included (P).
glycerol, 5 mmol/L MgCl2, 2.5 mmol/L EDTA, 2.5 mmol/L perature. The density of specific NF-B complex was
determined with a laser scanning densitometer and im-dithiothreitol (DTT), 250 mmol/L NaCl, 50 mmol/L Tris-
HCl (pH 7.5), 0.25 mg/mL poly[dl-dC]-poly[dl-dC] and age analysis software (BAStation; Fuji Photo Film Co.,
Ltd., Tokyo, Japan) as previously described [35].1 L of 32P-labeled (50,000 cpm counting) oligonucleo-
tides in a total volume of 10 L. In the competition
Western blot analysis of VCAM-1assays, a 100-fold excess of unlabeled NF-B consensus
or mutant NF-B oligonucleotides (5	-AGTTGAGGC Vascular cell adhesion molecule-1 protein levels in
cortical tissue were determined according to a previouslyAACGGTCCCAGGC-3	) was added to labeled NF-B
consensus oligonucleotides. After the addition of 1L of described method [16], with minor modifications. In
brief, cortical tissue was homogenized in Tris buffer withgel-loading buffer (250 mmol/L Tris-HCl, pH 7.5, 0.2%
bromophenol blue, 40% glycerol), the DNA-protein proteinase inhibitors (Roche Molecular Biochemicals).
After determination of the protein concentration withcomplexes were resolved by electrophoresis on a 7%
polyacrylamide gel in TBE buffer as previously described the Bio-Rad protein assay kit, protein samples (40 g)
were mixed with reducing buffer, heated at 100C for[34]. The gel was run at 150 V for 90 minutes and then
dried at 80C with a gel drier. Autoradiographs were five minutes and then subjected to 7.5% SDS-PAGE. The
separated proteins were electrophoretically transferred toprepared by exposing the dried gel to X-ray film with
intensifying screens for three to six hours at room tem- nitrocellulose membranes. The blots were blocked in 5%
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Fig. 3. Time course of nuclear factor-B
(NF-B) activity in protein-overloaded rats.
A representative autoradiogram of an electro-
phoretic mobility shift assay for NF-B in nu-
clear extracts from the renal cortex at 0 to 3
weeks after the start of daily bovine serum
albumin (BSA) injections is shown (A ). Lanes
1 and 2, rats at 0 and 3 weeks of daily intraperi-
toneal saline injection (control); lanes 3 to 6,
AdexlacZ-treated rats at 0 to 3 weeks of pro-
tein overload; lanes 7 to 10, AdexIBN-
treated rats at 0 to 3 weeks of protein overload.
Competition assay was performed to deter-
mine the binding specificity of the NF-B oli-
gonucleotides (B). The binding reactions were
performed with nuclear proteins from Adex-
lacZ-treated rats at 3 weeks of protein over-
load (lane 1), in the presence of a 100-fold
excess of unlabeled consensus (lane 2) or mu-
tant (lane 3) oligonucleotide competitors. Nu-
clear extracts obtained from AdexlacZ-treated
rats at 3 weeks of protein overload were incu-
bated with or without (lane 1) anti-p50 (lane
2) or anti-p65 (lane 3) antibody and analyzed
for NF-B binding activity. Brackets indicate
the positions of specific NF-B complex. An
arrowhead indicates the position of super-
shifted complex.
Fig. 4. Densitometric analysis of the auto-
radiographic results at one (A ) and three (B )
weeks of protein overload. Values obtained
from electrophoretic mobility shift assays for
NF-B in nuclear extracts from the renal cor-
tex at one and three weeks after the start of
daily bovine serum albumin (BSA) injections
were normalized and expressed as percent-
ages of the control. Control rats were injected
with saline daily. Rats loaded with BSA had
been injected with saline, AdexlacZ or Adex-
IBN one week before the start of protein
overload. Data are means SEM from 4 rats.
*P  0.05 vs. control values. #P  0.05 vs.
values of saline-treated rats with BSA loading.
**P 0.05 vs. values of AdexlacZ-treated rats.
nonfat milk and incubated for four hours at 22C with the were compared by Kruskal-Wallis test, followed by the
Mann-Whitney U test. Values of P  0.05 were consid-primary polyclonal antibody against VCAM-1 (dilution
1:100; Santa Cruz Biotechnology), and then for one hour ered statistically significant.
with a secondary antibody conjugated to horseradish per-
oxidase (dilution 1:500; Amersham Life Science). Immu-
RESULTS
noreactive bands were visualized by enhanced chemilumi-
In vivo gene transfer of -galactosidase into tubular cellsnescence (ECL; Amersham Life Science). Densitometric
analysis was performed with the NIH image program As previously described [20], injection of AdexlacZ
into renal artery resulted in the expression of -galactosi-(Bethesda, MD, USA).
dase in tubular epithelial cells at day 7, as shown in Figure
Statistics 1A. The expression of -galactosidase gradually decreased
at days 14 and 21 (Fig. 1 B, C) and only few -galactosi-All data are expressed as means  SEM. Multiple
parametric comparisons were evaluated by analysis of dase-positive cells were found at day 28 (data not shown).
The expression of -galactosidase was not observed invariance (ANOVA), followed by Fisher’s protected least
significant difference test. The scores for tubulointersti- either glomerular or interstitial areas at any time. No
-galactosidase-transduced cells could be detected intial scarring, glomerulosclerosis, and immunostaining
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Fig. 5. Cortical expression of VCAM-1 after
one week of protein overload. Protein levels
of VCAM-1 in the cortical tissue were deter-
mined by Western blotting and are shown in
the upper panel. Lanes 1 and 2, rats after one
week of daily intraperitoneal saline injections;
lanes 3 and 4, saline-injected rats after one
week of protein overload; lanes 5 and 6, Adex-
lacZ-injected rats after one week of protein
overload; lanes 7 and 8, AdexIBN-injected
rats after one week of protein overload. As
shown in the lower panel, values obtained by
densitometric analysis of Western blots for
VCAM-1 were normalized and expressed as
percentages of the control. Data are means 
SEM from 3 rats. *P 0.05 vs. control values;
#P  0.05 vs. values of saline-injected rats
with protein overload; **P  0.05 vs. values
of AdexlacZ-injected rats.
Fig. 6. Representative photomicrographs of
VCAM-1 immunostaining in kidney sections
after one week of protein overload. (A ) Rats
without protein overload. (B ) Saline-injected
rats with protein overload. (C ) AdexlacZ-
injected rats with protein overload. (D ) Adex-
IBN-injected rats with protein overload
(original magnification 200).
other organs including liver (Fig. 1D) and heart (data not cortices at one, four, and seven days after AdexIBN
shown). There was no X-gal staining in the cortex of rats injection was reverse transcribed and amplified using
injected with saline instead of AdexlacZ (Fig. 1E). specific primers. As shown in Figure 2, the 712 bp frag-
ment was amplified from AdexIBN-injected group
Expression of IBN in the renal cortex samples, but not from control samples. Although the
intensity of the band tended to be decreased on day 7,Transcription of AdexIBN was detected by RT-
PCR using specific primers. RNA extracted from the a faint band of AdexIBN still could be detected. No
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Fig. 7. Time course of urinary protein excre-
tion of rats with () or without (;) bovine
serum albumin (BSA) loading. Rats loaded
with BSA had been injected with saline ( ),
AdexlacZ ( ), or AdexIBN( ) one week
before the start of protein overload. *P 
0.05, vs. control values.
Table 1. Biochemical profile of rats with or without (control) protein overload for 3 weeks
Control Saline AdexlacZ AdexIBN
Body weight g 24426.7 2089.6 22715.0 23419.1
Kidney weight g 1.750.19 2.420.27a 2.890.19a 2.040.18c
Kidney/body weight % 0.720.14 1.150.79a 1.270.28a 0.870.46b,c
Blood pressure mm Hg 1196.8 1275.3 1449.9 14015.9
Serum albumin g/dL 3.800.13 5.180.39a 4.930.39a 5.000.40a
Total cholesterol mg/dL 66.25.41 64.85.36 76.05.51 56.07.62
Serum creatinine mg/dL 0.350.02 0.360.03 0.330.03 0.360.04
24-Hour CCr mL/min 1.260.17 1.230.10 1.450.13 1.130.26
Rats with protein overload had been injected with saline, AdexlacZ as a control vector or AdexIBN one week before the start of protein overload. Data
represent mean valuesSEM from 5 rats of each group. 24-Hour CCr is 24-hour creatinine clearance.
aP  0.05 vs. control values
bP  0.05 vs. values of saline-treated group
cP  0.05 vs. values of AdexlacZ-treated group
bands of this size were obtained from the AdexIBN- treated rats (Fig. 3A, lanes 3 to 6). By contrast, in Adex-
IBN-injected rats, NF-B activation was markedly re-injected group samples without reverse transcriptase.
duced (Fig. 3A, lanes 7 to 10). As shown in Figure 3B,
Time course of cortical NF-B activation in the NF-B/DNA bands were abolished by the unlabeled
proteinuric rats consensus oligonucleotides, but not by the mutant oligo-
nucleotides. Treatment of nuclear extracts with a specificNuclear factor-B DNA-binding activities were as-
sessed in whole cortical nuclear extracts from rats with anti-p65 antibody resulted in a supershift of the NF-B/
DNA bands, demonstrating the presence of p65 in theand without protein overload by EMSA (Fig. 3). In rats
without a protein overload, the incubation of cortical bands (Fig. 3C). By contrast, antibody to p50 did not
produce any change in the NF-B/DNA bands. Densito-nuclear extracts with labeled consensus NF-B oligonu-
cleotides produced weak bands (Fig. 3A, lanes 1 and 2). metric analysis revealed the treatment of proteinuric rats
with AdexIBN to prevent the cortical activation ofThe activation of NF-B was induced at one week,
peaked at two weeks, and persisted for at least three NF-B at one and three weeks (Fig. 4). The cortical
activation of NF-B in the proteinuric rats that had notweeks after initiating protein overload in AdexlacZ-
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Fig. 8. Representative photomicrographs of periodic acid-Schiff (A, C, E, and G) and Masson’s trichrome (B, D, F, and H ) staining of kidney
sections at 3 weeks after the start of protein overload. (A and B) Rats without protein overload. (C and D) Saline-injected rats with protein
overload. (E and F) AdexlacZ-injected rats with protein overload. (G and H) AdexIBN-injected rats with protein overload (original magnification
200).
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been injected with adenovirus was similar in extent to
the activation in the AdexlacZ group at one week.
Expression of VCAM-1
To investigate whether AdexIBN attenuated induc-
tion of an NF-B dependent molecule, we examined the
cortical expression of VCAM-1 in the early phase of the
renal injury. Western blot analysis revealed that protein
overload induced marked increases in VCAM-1 protein
in the renal cortical tissue of saline- and AdexlacZ-injected
rats (Fig. 5). As shown in Figure 6, the up-regulation of
VCAM-1 was mainly observed in proximal tubular cells,
with marked induction in the basolateral portion of the
epithelium. Occasional expression of VCAM-1 also was
observed in glomerular and interstitial areas. The levels
of VCAM-1 protein were significantly lower in rats in-
jected with AdexIBN (Figs. 5 and 6).
Biochemical profile
As shown in Figure 7, protein-overloaded rats devel-
oped significant proteinuria. The levels of urinary protein
excretion did not differ significantly among groups in-
jected with saline, AdexlacZ, and AdexIBN during
the course of BSA overload. Kidney weight and the
ratio of kidney/body weight were significantly greater in
protein-overloaded rats that had been injected with sa-
line or AdexlacZ than in the control group (Table 1).
The increase in the ratio of kidney/body weight was
significantly attenuated in the AdexIBN-treated group
compared to the saline- and AdexlacZ-treated groups.
Serum albumin levels of rats with protein overload were
significantly higher than those of controls. Blood pres-
sure, total cholesterol, serum creatinine, and 24-hour
creatinine clearance did not differ significantly among
the groups at sacrifice.
Light microscopy studies
In accordance with previous reports [5, 18], light mi-
croscopic analysis revealed protein overload to induce
marked tubulointerstitial injury in the renal cortices of
saline- and AdexlacZ-injected rats at three weeks (Fig. 8).
The tubular changes consisted of tubular cell brush bor-
der loss, cellular atrophy, and basement membrane thick-
ening. The interstitial space was expanded due to an
increase in mononuclear inflammatory cell infiltration,
Fig. 9. Tubulointerstitial scarring and glomerulosclerosis scores and interstitial edema, and fibrosis. In contrast, kidneys in-
number of interstitial mononuclear cells in rats with or without protein
jected with AdexIBN showed minor tubulointerstitialoverload for 3 weeks. Rats with protein overload had been injected
with saline, AdexlacZ, or AdexIBN one week before the start of injury as compared to the saline- and AdexlacZ-injected
protein overload. Data are means  SEM from 5 rats. *P  0.05 vs. groups. Sections were scored according to the severity
control values; #P 0.05 vs. values of saline-injected rats with protein
of tubulointerstitial scarring and glomerulosclerosis atoverload; **P  0.05 vs. values of AdexlacZ-injected rats.
three weeks after protein overload (Fig. 9). While pro-
tein overload induced a marked increase in the tubulo-
interstitial scarring score in the saline- and AdexlacZ-
treated groups, the increase in the score was significantly
attenuated in rats infected with AdexIBN. There was
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Fig. 10. Representative photomicrographs of immunostaining for TGF- (A, B, and C) and fibronectin (D, E, and F) in kidney sections at three
weeks after protein overload. (A and D) Rats without protein overload. (B and E) AdexlacZ-treated rats with protein overload. (C and F)
AdexIBN-treated rats with protein overload (original magnification 100).
a slight increase in the glomerulosclerosis score in pro- suggest the possibility of AdexIBN being utilized as
a therapeutic tool.teinuric rats, but no significant differences were observed
To investigate the process of tubulointerstitial injuryamong the groups. The number of interstitial mononu-
associated with proteinuria, we selected a non-immuno-clear cells was increased in the saline- and AdexlacZ-
genic rat model of tubulointerstitial injury induced bytreated groups, while the increase was markedly attenu-
protein overload. Since the levels of protein excretionated in rats injected with AdexIBN (Fig. 9).
did not differ between the AdexIBN and AdexlacZ
groups, tubular epithelial cells were considered to haveExpression of TGF- and fibronectin
been subjected to the same protein load in both groups.Since increased levels of interstitial TGF- and fibro-
This finding indicates that our experimental conditionsnectin were reportedly associated with interstitial fibrosis
were appropriate for investigating the role of NF-Bin uninephrectomized rats with protein overload [5], we
activation in the formation of tubulointerstitial injurynext investigated the expressions of these proteins. Strong
induced by protein overload.focal and segmental staining for TGF- and fibronectin
Previous reports have demonstrated that the distribu-was observed in the interstitial space in AdexlacZ-infected
tion of gene products transduced by adenovirus in the
rats, whereas staining was much less intense in Adex-
kidney depends on the conditions of viral administration
IBN-infected rats (Fig. 10). No significant staining was and on the transfected species. When the adenoviral
observed without primary antibodies (data not shown). vector is infused via the rat ureter, tubular cells in the
Semiquantitative scoring revealed that tubulointersti- papilla and medulla are the predominant sites of trans-
tial immunostaining scores for TGF- and fibronectin duction [20]. While Sukhatme’s group successfully trans-
were significantly lower in rats treated with AdexIBN duced a reporter gene in rat renal vasculature by infusing
than in AdexlacZ-treated rats (Fig. 11). Weak staining the adenovirus via the renal artery with venous clamping
for TGF- and fibronectin in the glomeruli of proteinuric and cold incubation [36], interstitial cells in the cortex
rats also was identified, but there were no differences be- are mainly transfected when a similar method is applied
tween the AdexlacZ and AdexIBN-infected groups. to dogs [37]. Glomerular cells have been reported to be
transfected also when porcine kidney is continuously
perfused for two hours [38]. In agreement with the find-
DISCUSSION ing by Moullier et al [20], we observed that the injection
This study demonstrates that NF-B activation in the of adenovirus into the rat renal artery with arterial
renal cortex plays a critical role in tubulointerstitial in- clamping resulted in a selective gene transfer into proxi-
mal tubular cells. Although Moullier et al reported ajury induced by proteinuria. The present results also
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transcripts in the renal cortices of the AdexIBN-
injected group was confirmed by RT-PCR analysis up
until 7 days after the administration of the adenovirus.
However, the IBN mRNA levels seemed to be de-
creased on day 7. These results suggest that IBN pro-
tein levels sufficient to prevent NF-B activation may
be maintained during the course of the renal injury de-
spite the decrease in the mRNA levels in the early stage.
In rats with protein overload, tubular cells have been
shown to be the major source of NF-B during the early
stage of interstitial injury, beginning as early as 24 hours
after the start of protein overload [10]. This report, to-
gether with the present results concerning the distribu-
tion of -galactosidase in tubular cells, supports the idea
that AdexIBN treatment prevents NF-B activation
in tubular cells during the early stage of interstitial injury
induced by protein overload. This notion is supported
further by the present finding that the increase in tubular
levels of VCAM-1, the expression of which is controlled
by NF-B in renal epithelial cells [39], was attenuated
by AdexIBN after one week of protein overload.
The present study demonstrates that the inhibition of
the NF-B pathway in the renal cortex by AdexIBN
attenuates tubulointerstitial injury, including interstitial
infiltration of mononuclear cells, in proteinuric rats.
Since VCAM-1 mediates localization and stimulation of
inflammatory cells [40, 41] and its expression is related
to the degree of tubulointerstitial injury in human glo-
merulonephritis [42], inhibition of VCAM-1 expression
by AdexIBN probably contributes to the attenuation
of tubulointerstitial injury to some extent. In addition
Fig. 11. Immunostaining scores for TGF- and fibronectin in the tubu- to VCAM-1, other NF-B dependent molecules, such as
lointerstitial space of rats with or without protein overload. Rats with
MCP-1 and RANTES [6, 7], may play some role in theprotein overload had been injected with AdexlacZ or AdexIBN one
week before the start of protein overload. Data represent mean val- development of NF-B dependent tubulointerstitial in-
ues  SEM from 4 rats. *P  0.05 vs. control values; **P  0.05 vs. jury induced by protein overload, although the precise
values of AdexlacZ-treated rats.
contributions of the various proinflammatory molecules
remain to be elucidated.
The reduced ratio of kidney weight/body weight in
rats treated with AdexIBN, as compared to the salinerather heterogeneous transduction of -galactosidase in
tubular cells, we observed a homogeneous distribution and AdexlacZ groups, indicates that the inhibition of
NF-B activation attenuates renal hypertrophy in pro-of -galactosidase-positive cells in renal cortex. The rea-
son for the discrepancy between these results is unclear. teinuric rats. In line with this observation, the histological
analysis revealed that interstitial fibrosis in proteinuricHowever, the status of the intrarenal hemodynamics
seems to be particularly important in determining the rats was reduced in rats treated with AdexIBN. These
effects of AdexIBN in part may be due to a reductiondistribution of adenoviral infection, since co-administra-
tion of vasodilators with adenovirus has been reported in the interstitial expression of TGF-, a profibrogenic
cytokine, and fibronectin, an interstitial matrix protein,to induce a significant change in the distribution of trans-
ferred gene products in the kidney [36]. Thus, the altered as demonstrated by immunostaining. Since interstitial
inflammatory cells have been shown to produce TGF-renal circulation caused by the heminephrectomy that
was performed prior to transfection in our study may in rats with protein overload [5], the attenuated infiltra-
tion of mononuclear cells is likely to contribute to thehave contributed to the homogeneous distribution of
adenovirus in the renal cortex. reduction in TGF- staining observed in the Adex-
IBN group.Treatment with AdexIBN prevented the NF-B ac-
tivation observed in AdexlacZ-injected rats throughout Largo et al reported the up-regulation of angiotensin-
converting enzyme and angiotensinogen in proximal tu-the course of protein overload. Expression of IBN
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interstitial inflammation and fibrosis in rats with protein-overloadbules of rats made proteinuric with protein overload,
proteinuria. Kidney Int 47:1546–1557, 1995
and suggested local production of angiotensin II to play 6. Wang Y, Rangan GK, Tay YC, Harris DC: Induction of mono-
a role in the tubulointerstitial injury in this model [28]. cyte chemoattractant protein-1 by albumin is mediated by nuclear
factor B in proximal tubule cells. J Am Soc Nephrol 10:1204–1213,Angiotensin II appears to participate in renal interstitial
1999fibrosis by stimulating production of TGF- and fibro- 7. Zoja C, Donadelli R, Colleoni S, et al: Protein overload stimu-
nectin in renal interstitial cells [43]. Since transcription lates RANTES production by proximal tubular cells depending
on NF-B activation. Kidney Int 53:1608–1615, 1998of angiotensinogen gene is controlled by NF-B [44],
8. Rangan GK, Wang Y, Tay YC, Harris DC: Inhibition of nucleardecreased local generation of angiotensin II also may factor-B activation reduces cortical tubulointerstitial injury in
contribute to the attenuated expression of TGF- and proteinuric rats. Kidney Int 56:118–134, 1999
9. Donadelli R, Abbate M, Zanchi C, et al: Protein traffic activatesfibrosis in the AdexIBN group.
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immune responses. Cell 80:321–330, 1995
present study provides direct evidence that NF-B acti- 14. Ouaaz F, Li M, Beg AA: A critical role for the RelA subunit of
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